Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PCO2 Gab as a Marker of Tissue Adequacy of Cardiac Output in Sever Shock State, Compared to Other Tissue Perfusion Indicators.

NCT05679778 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05679778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05679778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PCO2 Gab as a Marker of Tissue Adequacy of Cardiac Output in Sever Shock State, Compared to Other Tissue Perfusion Indicators.
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2023
Completion date
January 30, 2024
Enrollment
137 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

shock